12.74 1.24 (10.78%) | 12-31 19:00 | |||||||||||||
|
|
Short term | ||||
Mid term | ||||
Targets | 6-month : | 15.99 | 1-year : | 17.21 |
Resists | First : | 13.69 | Second : | 14.73 |
Pivot price | 12.73 | |||
Supports | First : | 12.01 | Second : | 9.99 |
MAs | MA(5) : | 12.73 | MA(20) : | 12.73 |
MA(100) : | 12.73 | MA(250) : | 11.98 | |
MACD | MACD : | 0 | Signal : | 0 |
%K %D | K(14,3) : | 26.7 | D(3) : | 26.7 |
RSI | RSI(14): 77.4 | |||
52-week | High : | 14.77 | Low : | 8.19 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.[ HCCC ] has closed Bollinger Bands are 0% narrower than normal.
If tomorrow: | Open lower | Open higher |
High: | 14.77 - 14.85 | 14.85 - 14.91 |
Low: | 11.84 - 11.92 | 11.92 - 11.99 |
Close: | 12.62 - 12.75 | 12.75 - 12.86 |
As of March 7, 2022, Healthcare Capital Corp. was acquired by Alpha Tau Medical Ltd., in a reverse merger transaction. Healthcare Capital Corp. does not have significant operations. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was incorporated in 2020 and is based in Wilmington, Delaware.
Tue, 08 Mar 2022
Latham & Watkins Advises Alpha Tau on Completed Business Combination with Healthcare Capital Corp. - Latham & Watkins LLP -
Mon, 07 Mar 2022
Alpha Tau Medical and Healthcare Capital Corp. Announce Completion of Business Combination - PR Newswire
Fri, 25 Feb 2022
Two new SPACs debut (GSRII, FGMC), and SNII Set to Close Next Week - TheStreet
Tue, 22 Feb 2022
DWAC Stock Pumped by Truth Social Downloads - TheStreet
Thu, 17 Feb 2022
DeSPACs get juiced, Circle gets a 2x valuation, JAAC ditches SPAC IPO plans - TheStreet
Thu, 03 Feb 2022
VMAC Swings, Wag! Gets a SPAC Deal, and DeSPAC TLMD is Going Private at $3 - TheStreet
Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Outperform |
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
Exchange:
NASDAQ
|
|
Sector:
Financial Services
|
|
Industry:
Shell Companies
|
|
Shares Out | 28 (M) |
Shares Float | 28 (M) |
Held by Insiders | 0 (%) |
Held by Institutions | 81.3 (%) |
Shares Short | 31 (K) |
Shares Short P.Month | 48 (K) |
EPS | 0 |
EPS Est Next Qtrly | 0 |
EPS Est This Year | 0 |
EPS Est Next Year | 0 |
Book Value (p.s.) | -0.7 |
Profit Margin | 0 % |
Operating Margin | 0 % |
Return on Assets (ttm) | 0 % |
Return on Equity (ttm) | 0 % |
Qtrly Rev. Growth | 0 % |
Gross Profit (p.s.) | 0 |
Sales Per Share | 0 |
EBITDA (p.s.) | 0 |
Qtrly Earnings Growth | 0 % |
Operating Cash Flow | 0 (M) |
Levered Free Cash Flow | 0 (M) |
PE Ratio | 0 |
PEG Ratio | 0 |
Price to Book value | -18.21 |
Price to Sales | 0 |
Price to Cash Flow | 0 |
Dividend | 0 |
Forward Dividend | 0 |
Dividend Yield | 0% |
Dividend Pay Date | Invalid DateTime. |
Ex-Dividend Date | Invalid DateTime. |